Targeting two receptors instead of the one targeted by fezolinetant, the new elinzanetant did not show the liver safety ...

PHILADELPHIA and VANCOUVER, British Columbia, Sept. 09, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” ...

Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that overcome tumor immune evasion and ...

Why is PDA’s Universe of Pre-Filled Syringes and Injection Devices Conference the must-attend event of the year? Get an ...

Lt. Gov. Mark Robinson of North Carolina, the Republican nominee for governor, vowed to stay in the race and pre-emptively ...

The Best of ASCO 2024 Annual Meeting, hosted by Hamad Medical Corporation (HMC) in partnership with the Qatar Cancer Society ...

TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical stage biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME), ...

First, a poster titled “Safety and ... About the North American Cystic Fibrosis Conference NACFC provides a collaborative and educational forum for all CF professionals. The educational elements of ...

Najera saw the business card tucked near the screen door of her Kansas home. She grabbed it and read the name. It was from a ...

MaaT Pharma (EURONEXT: MAAT – the "Company"), a clinical-stage biotechnology company and a leader in the development of ...

Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that overcome tumor immune evasion and drug resistance, today ...